Nordic Vaccine A/S

is a vaccine research and development company, with focus on the development and commercialization of new vaccines for prophylactic and therapeutic use.

The company's development program is based on its proprietary immune stimulating nano-particles, Posintro™, that combines safe and efficient delivery of vaccines with optimal immune responses.

Beside traditional injection, the unique features of these nano-particles enable various forms of needle-free delivery, as applied in a new vaccine patch system: TransVac™. 

 Welcome to the future of vaccines!